GlaxoSmithKline CR`s Shareholders' Equity reached 1,520 CZK mil in 2017. This is 0.266 % less than in the previous year.
Buy Shareholders' Equity data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
Amgen Czech Republic | CZK mil | ... | ... | ... | ... | ... | 169 | 198 | 167 | 207 | 183 | ||||||||
Bayer Czech Republic | CZK mil | ... | ... | ... | 460 | 289 | 286 | 243 | 246 | ||||||||||
GlaxoSmithKline Czech Republic | CZK mil | ... | ... | ... | 1,363 | 1,369 | 1,340 | 1,301 | 1,338 | ||||||||||
Merck Czech Republic | CZK mil | ... | ... | 225 | 289 | 316 | 351 | 419 | |||||||||||
Novartis Czech Republic | CZK mil | 238 | 292 | 340 | 423 | 505 | |||||||||||||
Pfizer Czech Republic | CZK mil | ... | ... | 1,034 | 1,043 | 1,562 | 1,696 | 1,180 | |||||||||||
Roche Czech Republic | CZK mil | ... | ... | ... | 1,065 | 1,104 | 1,239 | 1,134 | 1,185 | ... | |||||||||
Sanofi-Aventis Czech Republic | CZK mil | ... | ... | ... | ... | 528 | 574 | 639 | 640 | 699 | |||||||||
Servier Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 33.2 | 46.8 | 60.4 | 75.2 | ||
Walmark | CZK mil | ... | ... | ... | 1,223 | 368 | 637 | 667 | -85.0 |